DRDGOLD Ltd (DRDGF) stock analysis
Close on Oct 19, 2026Market cap $1.96BP/E 14.5Yield –
StockData Score
Prices as of Oct 30, 2026How the score works
Weak5 of 30 checks passed
Drdgold passes 5 of the 30 checks behind our score; 23 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Revenue growing 10%+ a year
Revenue grew 15.5% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 25.6% a year over the last three fiscal years.
Interest well covered
Operating income covers interest expense 39.7 times.
Gross margin improving
Gross margin was 39.7% over the last twelve months, against 29.0% a year earlier.
What to watch
Growing slower than the industry
Revenue grew 26.3% over the last twelve months; the Materials median is 51.1%.
No dividend
Drdgold has not paid a dividend in the last twelve months.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 15.5% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 25.6% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 26.3% over the last twelve months; the Materials median is 51.1%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin improving
Gross margin was 39.7% over the last twelve months, against 29.0% a year earlier.
Past performance0/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest well covered
Operating income covers interest expense 39.7 times.
Short-term assets cover short-term debts
Current assets are 2.28 times current liabilities.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
Drdgold has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Drdgold. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $5.84M
- Value traded per 1% price move
- $3.06M
Downside
High risk
- Typical loss in a bad month
- 25.7%
- Volatility (annualized)
- 57%
- Sharpe ratio, 1 year
- -0.19
- Beta to the S&P 500 (5Y)
- 0.60
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2015 to 2025
Gross margin
Operating margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +26.3% | +15.5% | +13.5% | – | |
| Gross profit | +73.0% | +31.5% | +20.2% | – | |
| Operating income | +80.9% | +30.7% | +25.5% | – | |
| EPS, diluted | +68.7% | +25.6% | +26.2% | – | |
| Free cash flow | – | +11.2% | +5.8% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Current ratio | – | 2.94 | 2.28 | |
| Interest coverage | 2.5× | 13.6× | 39.7× | |
| Inventory turnover | – | 9.4× | 9.7× | |
| Capex to revenue | 4.1% | 4.3% | 28.6% | |
| Diluted shares | 422M | 784M | 866M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Drdgold generated 10.08B ZAR from operations and spent 10.20B ZAR on capital expenditure, dividends and share buybacks. 72% of that went back into the business.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero3.51B ZAR
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income3.51B ZAR vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.57 → 2.28
- No dilutionShare count did not rise866M → 866M
- Gross margin improvedGross margin up on the prior year29.00% → 39.74%
- More efficientAsset turnover rose0.77 → 0.83